Intravenous Infusions Plc (GHSE:IIL)
Ghana
· Delayed Price · Currency is GHS 0.0500
0.00 (0.00%)
At close: Feb 16, 2026
Intravenous Infusions Ratios and Metrics
Market cap in millions GHS. Fiscal year is January - December.
Millions GHS. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 14 | 14 | 14 | 14 | 11 | 14 | Upgrade
|
| Market Cap Growth | -32.73% | - | - | 25.00% | -20.00% | 6.02% | Upgrade
|
| Enterprise Value | 24 | 21 | 24 | 28 | 27 | 25 | Upgrade
|
| Last Close Price | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 | Upgrade
|
| PE Ratio | - | - | - | 5.40 | - | 11.97 | Upgrade
|
| PS Ratio | 1.47 | 1.48 | 0.55 | 0.44 | 0.54 | 0.61 | Upgrade
|
| PB Ratio | 1.20 | 1.20 | 0.86 | 0.79 | 0.74 | 0.75 | Upgrade
|
| P/TBV Ratio | 1.20 | 1.20 | 0.87 | 0.80 | 0.75 | 0.75 | Upgrade
|
| P/FCF Ratio | - | - | 2.19 | 5.75 | 24.26 | - | Upgrade
|
| P/OCF Ratio | - | - | 1.68 | 3.25 | 3.82 | 4.16 | Upgrade
|
| EV/Sales Ratio | 2.56 | 2.25 | 0.97 | 0.89 | 1.31 | 1.09 | Upgrade
|
| EV/EBITDA Ratio | - | - | 16.52 | 3.82 | - | 14.01 | Upgrade
|
| EV/EBIT Ratio | - | - | 29.70 | 4.29 | - | 20.14 | Upgrade
|
| EV/FCF Ratio | -16.85 | - | 3.88 | 11.72 | 58.71 | - | Upgrade
|
| Debt / Equity Ratio | 0.90 | 0.90 | 0.55 | 0.76 | 1.09 | 0.90 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 5.99 | 1.79 | - | 9.29 | Upgrade
|
| Debt / FCF Ratio | - | - | 1.41 | 5.50 | 35.65 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.89 | 0.89 | 0.46 | 0.74 | 1.03 | 0.85 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.56 | -1.56 | 4.98 | 1.76 | -5.74 | 8.83 | Upgrade
|
| Net Debt / FCF Ratio | -7.15 | -7.15 | 1.17 | 5.38 | 33.55 | -4.04 | Upgrade
|
| Asset Turnover | 0.23 | 0.23 | 0.55 | 0.67 | 0.44 | 0.54 | Upgrade
|
| Inventory Turnover | 1.31 | 1.31 | 2.17 | 2.19 | 1.62 | 1.76 | Upgrade
|
| Quick Ratio | 0.49 | 0.49 | 0.58 | 0.81 | 0.83 | 1.31 | Upgrade
|
| Current Ratio | 0.83 | 0.83 | 0.83 | 1.11 | 1.15 | 1.86 | Upgrade
|
| Return on Equity (ROE) | -37.92% | -37.92% | -3.87% | 15.85% | -21.22% | 6.33% | Upgrade
|
| Return on Assets (ROA) | -10.88% | -10.88% | 1.12% | 8.73% | -4.29% | 1.83% | Upgrade
|
| Return on Invested Capital (ROIC) | -32.86% | -31.61% | 3.06% | 15.79% | -10.05% | 3.13% | Upgrade
|
| Return on Capital Employed (ROCE) | -33.30% | -33.30% | 4.00% | 25.40% | -12.60% | 3.80% | Upgrade
|
| Earnings Yield | -37.76% | -37.76% | -4.69% | 18.54% | -31.97% | 8.36% | Upgrade
|
| FCF Yield | -10.31% | -10.31% | 45.60% | 17.39% | 4.12% | -28.13% | Upgrade
|
| Dividend Yield | 5.60% | - | 5.60% | 8.43% | - | - | Upgrade
|
| Payout Ratio | - | - | - | - | - | 61.94% | Upgrade
|
| Buyback Yield / Dilution | -0.44% | -0.44% | - | - | - | - | Upgrade
|
| Total Shareholder Return | 5.16% | -0.44% | 5.60% | 8.43% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.